Abstract

Abstract:

The present disclosure relates to a novel crystalline forms of 4-[3­chloro-4-(N’-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide ethanesulfonate which is represented by the following structural formula-1b, which is referred to as Lenvatinib ethanesulfonate.

Formula-1b

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS